Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenib.
Department of Medicine, Baylor College of Medicine, 1709 Dryden Road, Houston, TX 77004, USA.
Premal D
PD
Lulla
Jonathan E
JE
Brammer
Salman
S
Bandeali
Garret R
GR
Lynch
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000556:secondary; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D011379:Prognosis; D012074:Remission Induction; D000077157:Sorafenib; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib